• 1
    Giovino G. A., Sidney S., Gfroerer J. C., O'Malley P. M., Allen J. A., Richter P. A. et al. Epidemiology of menthol cigarette use. Nicotine Tob Res 2004; 6: S67S81.
  • 2
    Garten S., Falkner R. V. Role of mentholated cigarettes in increased nicotine dependence and greater risk of tobacco-attributable disease. Prev Med 2004; 38: 7938.
  • 3
    Benowitz N. L., Herrera B., Jacob P. Mentholated cigarette smoking inhibits nicotine metabolism. J Pharmacol Exp Ther 2004; 310: 120815.
  • 4
    Ahijevych K., Garrett B. E. Menthol pharmacology and its potential impact on cigarette smoking behavior. Nicotine Tob Res 2004; 6: S17S28.
  • 5
    Kreslake J. M., Wayne G. F., Connolly G. N. The menthol smoker: tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior. Nicotine Tob Res 2008; 10: 70515.
  • 6
    Pletcher M., Hulley B., Houston T., Keife C., Benowitz N., Sidney S. Menthol cigarettes, smoking cessation, atherosclerosis, and pulmonary function: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Arch Intern Med 2006; 166: 191522.
  • 7
    Muscat J. E., Richie J. P., Stellman S. D. Mentholated cigarettes and smoking habits in whites and blacks. Tob Control 2002; 11: 36871.
  • 8
    Okuyemi K., Ebersole-Robinson M., Nazir N., Ahluwalia J. Black menthol and nonmenthol smokers: differences in smoking and cessation experiences. J Natl Med Assoc 2004; 96: 120811.
  • 9
    Murray R., Connett J., Skeans M., Tashkin D. Menthol cigarettes and health risks in Lung Health Study data. Nicotine Tob Res 2002; 9: 1017.
  • 10
    Castro F. G. Physiological, psychological, social, and cultural influences on the use of menthol cigarettes among Blacks and Hispanics. Nicotine Tob Res 2004; 6: S29S41.
  • 11
    Kabat G. C., Hebert J. R. Use of mentholated cigarettes and oropharyngeal cancer. Epidemiology 1994; 5: 1838.
  • 12
    Sidney S., Tekawa I. S., Friedman G. D., Sadler M. C., Tashkin D. P. Mentholated cigarette use and lung cancer. Arch Intern Med 1995; 155: 72732.
  • 13
    Carpenter C. L., Jarvik M. E., Morgenstern H., McCarthy W. J., Jarvik M. E. Mentholated cigarette smoking and lung-cancer risk. Ann Epidemiol 1999; 9: 11420.
  • 14
    Gardiner P. S. The African Americanization of menthol cigarette use in the United States. Nicotine Tob Res 2004; 6: S55S65.
  • 15
    Yerger V. B., Przewoznik J., Maline R. E. Racialized geography, corporate activity, and health disparities: tobacco industry targeting of inner cities. J Health Care Poor Underserved 2007; 18: 1038.
  • 16
    Sutton C. D., Robinson R. G. The marketing of menthol cigarettes in the United States: populations, messages, and channels. Nicotine Tob Res 2004; 6: S83S91.
  • 17
    US Department of Health and Human Services. Tobacco use among U.S. racial/ethnic minority groups—African Americans, American Indians and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1998.
  • 18
    Shiffman S., Kirchner T. R., Ferguson S. G., Scharf D. M. Patterns of intermittent smoking: an analysis using Ecological Momentary Assessment. Addict Behav 2009; 34: 5149.
  • 19
    Hassmiller K. M., Warner K. E., Mendez D., Levy D. T., Romano E. Nondaily smokers: who are they? Am J Public Health 2003; 93: 13217.
  • 20
    Schane R. E., Ling P. M., Glantz S. A. Health effects of light and intermittent smoking: a review. Circulation 2010; 121: 151822.
  • 21
    Schane R., Glantz S., Ling P. Nondaily smoking: an increasingly prevalent pattern. Arch Intern Med 2009; 169: 17424.
  • 22
    Levy D. E., Biener L., Rigotti N. A. The natural history of light smokers: a population-based cohort study. Nicotine Tob Res 2009; 11: 15663.
  • 23
    Trinidad D. R., Perez-Stable E. J., Emery S. L., White M. M., Grana R. A., Messer K. S. Intermittent and light daily smoking across racial/ethnic groups in the United States. Nicotine Tob Res 2009; 11: 20310.
  • 24
    Escobedo L. G., Anda R. F., Smith P. F., Remington P. L., Mast E. E. Sociodemographic characteristics of cigarette smoking initiation in the United States—implications for smoking-prevention policy. JAMA 1990; 264: 15505.
  • 25
    Office of Applied Studies. Results from the 2002 National Survey on Drug Use and Health: National Findings. DHHS Publication no. SMA 03–3836, NHSDA Series H–22. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2003.
  • 26
    Henningfield J. E., Benowitz N. L., Ahijevych K., Garrett B. E., Connolly G. N., Wayne G. F. Does menthol enhance the addictiveness of cigarettes? An agenda for research. Nicotine Tob Res 2003; 5: 911.
  • 27
    Hyland A., Garten S., Giovino G. A., Cummings K. M. Mentholated cigarettes and smoking cessation: findings from COMMIT. Tob Control 2002; 11: 1359.
  • 28
    DeLancey J. O. L., Thun M. J., Jemal A., Ward E. M. Recent trends in black–white disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev 2008; 17: 290812.
  • 29
    Pérez-Stable E. J., Herrera B., Jacob P., Benowitz N. L. Nicotine metabolism and intake in black and white smokers. JAMA 1998; 280: 1526.
  • 30
    Braveman P. A., Cubbin C., Egerter S., Chideya S., Marchi K. S., Posner S. et al. Socioeconomic status in health research: one size does not fit all. JAMA 2005; 294: 287988.
  • 31
    Braveman P. A., Cubbin C., Marchi K. S., Egerter S., Chavez G. F. Measuring socioeconomic status/position in studies of racial/ethnic disparities: maternal and infant health. Public Health Rep 2001; 116: 44963.